Stay updated on ISIS 443139 in Early Huntington's Disease: Clinical Trial
Sign up to get notified when there's something new on the ISIS 443139 in Early Huntington's Disease: Clinical Trial page.

Latest updates to the ISIS 443139 in Early Huntington's Disease: Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a backend version update with no user-facing content changes.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows Revision: v3.4.2 replacing Revision: v3.4.1; no changes to study details, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. This is an internal versioning update and does not change any trial details, eligibility criteria, or results displayed.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded a glossary toggle and updated QC metadata to 'Last Update Submitted that Met QC Criteria' with revision v3.4.0, while removing the older label 'Last Update Submitted that met QC Criteria', the previous revision v3.3.4, and adjusting 'No FEAR Act data' wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a Locations section including British Columbia as a study site. Removed the British Columbia Locations entry and the HHS Vulnerability Disclosure link; updated page revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to ISIS 443139 in Early Huntington's Disease: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ISIS 443139 in Early Huntington's Disease: Clinical Trial page.